GlobeNewswire

Barings Completes Sale of Wireless Infrastructure Group

Dela

LONDON, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it has sold its investment in Wireless Infrastructure Group ("WIG" or the "Company") to 3i Infrastructure plc ("3i Infrastructure").

Headquartered in Edinburgh, Scotland, WIG is an independent communications infrastructure provider. The Company operates a portfolio of over 2,000 communication towers and is the United Kingdom's market leader for the deployment of neutral host distributed antenna system networks needed to deliver mobile signals to large public venues. Barings initially made its controlling investment in WIG in December 2012, and the transaction comes as the Company continues to scale up its deployment of high capacity, 5G-ready wireless infrastructure. This includes new communication towers serving rural communities, together with small cells and fiber networks in busy urban centers.

 "We are delighted that 3i Infrastructure has extended its investment into WIG," said Scott Coates, CEO of Wireless Infrastructure Group. "WIG is busy investing in new infrastructure across the United Kingdom, from new towers in the Highlands of Scotland to 5G-ready small-cell networks that will connect self-driving cars in the West Midlands.  Barings has been a great partner and WIG is well positioned to continue our scale up."

"Barings' five-year investment in WIG has been highly successful, with the company doubling in scale, developing a leading position in small cells, expanding its capabilities and delivering great service to customers," said Matt Sandoval, Head of Telecom and a managing director in Barings' Private Equity / Real Assets Group. "WIG is a prime example of the real asset and asset-based private equity investments that Barings targets. With WIG, we early on identified a macro theme that has played out favorably and yielded outstanding results for our clients."

With over 650 investment professionals globally, including more than 250 dedicated solely to alternative investments, Barings leverages its global presence and local expertise to source investment opportunities worldwide. Within Barings, the Barings Alternative Investments group seeks to find differentiated sources of return in global real estate, private equity and real assets through; a Private Equity / Real Assets group that focuses on control investments within real assets and asset-based businesses; a Real Estate group that offers a diverse range of opportunities across the four quadrants in both public and private real estate equity and debt markets; and a Funds and Co-Investments group that makes minority investments in unaffiliated, third-party private equity funds, as well as related equity co-investments, and transactions in the private equity secondary market. Learn more at www.barings.com /strategies.

About Wireless Infrastructure Group
Wireless Infrastructure Group is an independent communications infrastructure provider headquartered in the Edinburgh with offices in London, Solihull, Bellshill, Basingstoke and the Netherlands. Following its launch in 2006, Wireless Infrastructure Group has invested in over 2,000 assets including communications towers and other wireless infrastructure. The business builds and operates communication towers in rural and suburban areas, together with fiber-based networks to enable mobile coverage in large buildings and on city streets. Wireless Infrastructure Group is fully independent of any network operator and invests in high capacity infrastructure available to all networks. For more information about Wireless Infrastructure Group, visit www.wirelessinfrastructure.co.uk.

About Barings
Barings is a $299 billion* global asset management firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. Part of MassMutual, Barings maintains a strong global presence with over 650 investment professionals and offices in 16 countries. Learn more at www.barings.com.

*As of Sept. 30, 2017

17-348232

Contact:  
Brian Whelan, Barings, 704.805.7244, brian.whelan@barings.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Barings via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum